openPR Logo
Press release

Infectious Disease Therapeutics Market – Gilead Sciences developed advance treatment of life-threatening diseases

01-24-2019 07:17 AM CET | Health & Medicine

Press release from: Market Data Forecast

Infectious Disease Therapeutics Market – Gilead Sciences

Recent Developments
Gilead Sciences is an American Biotechnology Company. It is a research based biopharmaceutical company that focuses on discovery, development and commercialization of innovative medicines. It primarily focuses on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. The company developed advanced treatment for life-threatening diseases with new therapeutic advancements.

To know more, read: https://www.marketdataforecast.com/market-reports/infectious-Disease-therapeutics-market-1320/

Market Segmentations
Market Data Forecast published a report named Infectious Disease Therapeutics Market. It is worth USD 105.13 Billion in 2018 and estimated to reach USD 154.18 Billion by the end of 2023 with a growing potential of 7.96 %.

Report segmented as:
Mode of Treatment:
• Introduction
• Drugs
• Vaccines

Distribution Channels:
• Hospitals
• Clinics

Based on the mode of treatment, vaccines are accounted for the largest share in the market. Under the distribution channel, hospitals are estimated for the highest growth in the market.

Geographical Segmentation:
By geography, the market is segmented into North America, Latin America, Europe, Middle East and Africa, and Asia-Pacific. North America is dominating the global market closely followed by Asia Pacific and Europe.

Key Market Players:
• F. Hoffmann-La Roche
• Gilead Sciences
• GlaxoSmithKline
• Johnson & Johnson

View sample and decide:
https://www.marketdataforecast.com/market-reports/infectious-Disease-therapeutics-market-1320/request-sample

Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: Market Data Forecast™
Address: Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Disease Therapeutics Market – Gilead Sciences developed advance treatment of life-threatening diseases here

News-ID: 1528133 • Views:

More Releases from Market Data Forecast

Personalized Nutrition Market is growing at a brisk pace
Personalized Nutrition Market is growing at a brisk pace
The global personalized nutrition market size is expected to be valued at USD 10.84 thousand units in 2024 and reach USD 21.80 thousand units by 2029, growing at a CAGR of 15.0% from 2024 to 2029. Global Personalized Nutrition Market Report Scope: • Market Size (2029): USD 21.80 thousand units • Market Size (2024): USD 10.84 thousand units • CAGR (2024 to 2029): 15% • Base Year: 2023 • Forecast Period: 2024 to 2029 • Segments
Anticipating the Future of the Antibodies Market
Anticipating the Future of the Antibodies Market
The Antibodies market size is expected to be valued at USD 183.7 billion in 2024 and reach USD 183.7 billion by 2029, growing at a CAGR of 11.31% from 2024 to 2029. Antibodies, also known as immunoglobulins, are Y-shaped proteins the immune system produces in response to foreign substances called antigens. Antibodies are employed in various applications, such as diagnostics, research, and therapeutics, which play a crucial role. Global Antibodies Market Report
The Power of Herbal Medicine in Healthcare Market
The Power of Herbal Medicine in Healthcare Market
The herbal medicine market size is expected to be valued at USD 215.4 billion in 2024 and reach USD USD 305.3 billion by 2029, growing at a CAGR of 7.22% from 2024 to 2029. Herbal medicines, derived from plants or plant parts like leaves, flowers, seeds, roots, and stems, have been utilized across diverse cultures for centuries due to their therapeutic properties. They can be prepared in various forms, such as
Innovative Surge Wearable Medical Devices Market Thrives
Innovative Surge Wearable Medical Devices Market Thrives
The global wearable medical devices market size is expected to be valued at USD 11194 million in 2024 and reach USD 28322 million by 2029, growing at a CAGR of 20.40 % from 2024 to 2029. Wearable medical devices are devices that customers can wear, such as activity trackers and smartwatches. These devices are designed to monitor and collect real-time data on customer health and fitness. Global Wearable Medical Devices Market

All 5 Releases


More Releases for Disease

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and